Page last updated: 2024-10-31

mianserin and Myelopathy

mianserin has been researched along with Myelopathy in 1 studies

Mianserin: A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors.
mianserin : A dibenzoazepine (specifically 1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine) methyl-substituted on N-2. Closely related to (and now mostly superseded by) the tetracyclic antidepressant mirtazapinean, it is an atypical antidepressant used in the treatment of depression throughout Europe and elsewhere.

Research Excerpts

ExcerptRelevanceReference
" dosage again displayed significant efficacy when administered at 15 min delaying treatment to 30 min resulted in only marginal therapeutic actions."1.29Characterization of mianserin neuroprotection in experimental spinal trauma: dose/route response and late treatment. ( Agresta, CA; Azim, S; Chavin, J; Kelly, G; Puniak, MA; Salzman, SK; Wang, L, 1994)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Salzman, SK1
Kelly, G1
Chavin, J1
Wang, L1
Puniak, MA1
Agresta, CA1
Azim, S1

Other Studies

1 other study available for mianserin and Myelopathy

ArticleYear
Characterization of mianserin neuroprotection in experimental spinal trauma: dose/route response and late treatment.
    The Journal of pharmacology and experimental therapeutics, 1994, Volume: 269, Issue:1

    Topics: Animals; Dose-Response Relationship, Drug; Drug Administration Routes; Edema; Ketanserin; Male; Mian

1994